Laura Keidan Martin is the national head of the firm’s Health Care practice and a member of the firm’s Board of Directors. She counsels health care industry participants including health systems, life sciences companies, national ancillary service providers, management companies, managed care organizations and private equity funds, helping them structure their affiliations, mergers, acquisitions, joint ventures, marketing practices and physician compensation arrangements to meet state and federal regulatory requirements. Laura regularly assists clients with government and internal investigations arising from Anti-Kickback Statute, Stark Act, billing/coding and False Claims Act allegations and advises on compliance with corporate integrity and deferred prosecution agreements. She also serves as lead counsel on complex transactions, often involving multiple parties and creative deal structures.
Laura’s antitrust practice covers the high-tech and manufacturing industries in addition to health care. She helps clients structure their operations, acquisitions and joint venture arrangements to minimize antitrust risk and provides representation in pre-merger reviews before the Federal Trade Commission and the Department of Justice.
